ECMO Devices Market Size, Share, Growth, and Industry Analysis, By Type (VV ECMO,VA ECMO,AV ECMO), By Application (Hospitals,Diagnostic Centre,Clinics,Ambulatory Surgical Centre), Regional Insights and Forecast to 2035

ECMO Devices Market Overview

The global ECMO Devices Market is forecast to expand from USD 296.38 million in 2026 to USD 310.08 million in 2027, and is expected to reach USD 445.06 million by 2035, growing at a CAGR of 4.62% over the forecast period.

The ECMO Devices Market is supported by the increasing adoption of extracorporeal life support across specialized critical care centers and the continuous expansion of ECMO programs worldwide. Growing investments in advanced intensive care infrastructure, higher patient volumes, and the establishment of dedicated ECMO centers are driving demand for ECMO consoles, oxygenators, and disposable circuit components. Adult patients represent approximately 72% of ECMO procedures, highlighting the strong demand for adult-focused respiratory and cardiac support systems.

The United States remains a key contributor to the global ECMO Devices Market due to its extensive network of specialized hospitals, established ECMO programs, and advanced transport capabilities. The increasing adoption of interfacility ECMO retrieval services, ongoing technological advancements, and expanding utilization in respiratory and cardiac critical care continue to strengthen market growth. These factors are encouraging healthcare providers to invest in portable ECMO platforms, integrated monitoring technologies, and comprehensive service solutions to improve clinical outcomes and operational efficiency.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising adoption of ECMO therapy for severe respiratory and cardiac conditions is accelerating demand for advanced ECMO systems, with adult patients accounting for approximately 72% of total procedures.
• Major Market Restraint: Workforce shortages remain a key challenge, with nearly 30% of healthcare facilities citing limited availability of trained ECMO specialists as a barrier to program expansion.
• Emerging Trends: Portable and transport-capable ECMO systems now represent around 30% of new procurements, reflecting the growing need for interfacility patient transport and mobile critical care.
• Regional Leadership: North America leads the global market with approximately 35% market share, supported by advanced healthcare infrastructure and widespread ECMO adoption.
• Competitive Landscape: Leading manufacturers appear in nearly 50% of procurement shortlists due to their broad product portfolios, technological innovation, and strong service capabilities.
• Market Segmentation: VV ECMO dominates the market, accounting for approximately 60% of total ECMO procedures because of its extensive use in respiratory support.
• Recent Development: Median annual ECMO procedures per center have increased to 15 cases, reflecting greater clinical experience, expanding treatment capacity, and higher utilization.

ECMO Devices Market Latest Trends

The ECMO Devices Market is experiencing steady growth driven by the expansion of clinical ECMO programs, rising adoption of transport-enabled systems, and increasing demand for disposable consumables. Portable ECMO platforms account for 30% of new equipment procurements, reflecting the growing need for patient mobility and interhospital critical care transport. Healthcare providers are also prioritizing user-friendly console designs to enable faster deployment and improve workflow efficiency during emergency procedures.

Another key trend is the increasing emphasis on operational efficiency, clinician training, and recurring consumable demand. Simplified console interfaces are included in 50% of newly specified devices to support rapid cannulation and stabilization, while hospitals continue to strengthen staff competency through structured training programs. At the same time, consistent use of oxygenators and pump disposable kits is reinforcing the consumables segment, creating long-term opportunities for manufacturers offering integrated training, technical support, and service solutions.

How is technological advancement driving the ECMO Devices Market?

Technological advancement is significantly driving the ECMO Devices Market through the introduction of compact, transport-capable ECMO systems, integrated monitoring technologies, and advanced oxygenator designs that improve clinical performance and ease of use. Modern ECMO consoles offer enhanced portability, digital monitoring, and simplified user interfaces, enabling faster deployment during emergencies and interhospital patient transfers. Additionally, improved biocompatible materials and high-precision flow monitoring are increasing treatment safety, reducing complications, and encouraging wider adoption of ECMO technology across critical care facilities.

ECMO Devices Market Dynamics

DRIVER

"Rising critical-care capacity and transport programs"

The growth of the ECMO Devices Market is driven by the continuous expansion of critical-care infrastructure and the increasing adoption of ECMO therapy in tertiary and quaternary hospitals. Healthcare systems are investing in dedicated ECMO programs to manage patients with severe respiratory failure, cardiogenic shock, and other life-threatening conditions that require prolonged cardiopulmonary support. The growing number of specialized ECMO centers and higher patient throughput are leading to greater utilization of advanced ECMO consoles, pumps, oxygenators, and monitoring systems. In parallel, hospitals are strengthening regional referral networks to ensure timely access to ECMO therapy for critically ill patients.

The development of dedicated ECMO transport programs has further accelerated market growth by enabling safe interfacility transfer of patients requiring continuous extracorporeal support. Around 25% of specialized patient transfers are now supported by ECMO retrieval teams, encouraging healthcare providers to invest in portable and transport-compatible ECMO systems. The need for rapid deployment, simplified operation, and improved clinical workflow is also driving demand for next-generation ECMO platforms with enhanced mobility, integrated monitoring, and user-friendly interfaces.

RESTRAINT

"Workforce and training bottlenecks"

The expansion of the ECMO Devices Market is constrained by the limited availability of highly trained professionals required to establish and sustain ECMO programs. Successful ECMO therapy depends on multidisciplinary teams comprising perfusionists, intensivists, surgeons, nurses, respiratory therapists, and ECMO specialists, all of whom require extensive technical expertise and continuous competency development. Many healthcare facilities, particularly smaller hospitals and emerging healthcare systems, face challenges in recruiting and retaining these specialized professionals, slowing the adoption of ECMO technology.

Approximately 30% of prospective ECMO centers identify workforce shortages as a primary barrier to program implementation. In addition to staffing constraints, ongoing education, simulation-based training, competency assessments, and certification requirements increase operational complexity and costs. These factors prolong program development timelines, limit the expansion of new ECMO centers, and reduce the pace of market penetration despite increasing clinical demand.

OPPORTUNITY

"Disposable kit and consumable recurring revenue"

Recurring demand for disposable oxygenators, tubing sets, cannulas, and circuit kits represents one of the strongest long-term growth opportunities in the ECMO Devices Market. Every ECMO procedure requires a new sterile circuit and oxygenator, ensuring continuous replacement demand regardless of the installed base of ECMO consoles. As hospitals expand ECMO programs and patient volumes continue to increase, procurement of disposable components rises proportionally, creating stable and predictable revenue streams for manufacturers.

Disposable consumables are required in 100% of ECMO treatment runs, making them a critical and recurring component of the market. Manufacturers are increasingly focusing on developing high-performance oxygenators, biocompatible coatings, and advanced circuit technologies that improve patient safety while supporting long-term clinical use. In addition, service contracts and bundled consumable supply agreements are strengthening customer relationships and creating sustainable business opportunities across established and emerging ECMO centers.

CHALLENGE

"Device regulation and supply chain disruptions"

The ECMO Devices Market continues to face challenges related to stringent regulatory requirements, quality assurance standards, and supply chain vulnerabilities. Manufacturers must comply with rigorous clinical validation, production quality controls, and post-market surveillance regulations before introducing new products or expanding into additional markets. Any regulatory review, manufacturing interruption, or corrective action can delay product availability and disrupt hospital procurement cycles, particularly for critical disposable components.

Supply disruptions have affected approximately 15% of regional consumable availability during certain periods, prompting hospitals to maintain larger contingency inventories to ensure uninterrupted patient care. In addition, dependence on specialized raw materials, limited manufacturing capacity, and global logistics challenges increase the risk of product shortages and longer delivery timelines. These factors create operational pressure for healthcare providers while requiring manufacturers to diversify production capabilities, strengthen supplier networks, and improve inventory resilience to maintain consistent market supply.

Why is demand increasing for the ECMO Devices Industry?

Demand for the ECMO Devices Industry is increasing due to the rising incidence of severe respiratory and cardiovascular diseases, expanding intensive care infrastructure, and growing adoption of extracorporeal life support in hospitals. Healthcare providers are investing in advanced ECMO programs to improve survival outcomes for critically ill patients, while increasing procurement of disposable oxygenators, circuit kits, and portable ECMO systems is supporting sustained market growth. The expansion of specialized ECMO retrieval services and clinician training programs is further strengthening industry demand.

ECMO Devices Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE 

VV ECMO

VV ECMO is the most widely adopted ECMO modality for managing severe respiratory failure, particularly in patients requiring prolonged extracorporeal respiratory support. It is extensively used in intensive care units because it provides effective oxygenation while allowing the lungs to recover, making it the preferred option for advanced respiratory management. Continuous advancements in oxygenators, dual-lumen cannulas, and portable ECMO systems are further improving treatment efficiency and expanding clinical adoption.

VV ECMO accounts for approximately 60% of overall ECMO procedures, reflecting its dominant role in respiratory care. The growing burden of acute respiratory diseases, expansion of specialized ECMO centers, and increasing availability of advanced critical care infrastructure continue to strengthen demand for VV ECMO systems and associated consumables.

VA ECMO

VA ECMO is primarily utilized for patients with severe cardiac failure or combined cardiopulmonary dysfunction, providing both circulatory and respiratory support during life-threatening conditions. It has become an essential therapy for cardiogenic shock, cardiac arrest, and post-cardiac surgery complications, with healthcare providers increasingly integrating advanced monitoring and portable ECMO technologies into emergency cardiac care.

VA ECMO represents nearly 35% of ECMO utilization worldwide, supported by the increasing prevalence of cardiovascular diseases and the growing adoption of extracorporeal cardiopulmonary resuscitation (ECPR). Rising investments in cardiac critical care units and improvements in ECMO technology continue to drive the expansion of this segment.

AV ECMO

AV ECMO serves a specialized role in extracorporeal support and is primarily used in select clinical settings where customized hemodynamic management is required. Although its application is limited compared to VV and VA ECMO, continuous research and technological innovation are improving system efficiency and expanding its use in niche therapeutic applications.

AV ECMO contributes approximately 5% of the overall ECMO modality market. Growing interest in specialized extracorporeal therapies, compact system designs, and advanced patient management technologies is supporting gradual adoption across selected critical care facilities.

BY APPLICATION 

Hospitals

Hospitals are the largest end users of ECMO devices because they possess advanced intensive care units, multidisciplinary ECMO teams, and specialized emergency care infrastructure. They perform the majority of ECMO procedures for patients with severe respiratory and cardiac failure while maintaining dedicated ECMO programs, retrieval services, and comprehensive critical care capabilities.

Hospitals account for approximately 70% of ECMO device utilization, driven by expanding ICU capacity, increasing investments in critical care infrastructure, and the growing adoption of advanced life-support technologies. Continuous procurement of ECMO consoles, oxygenators, and disposable circuits further reinforces the segment's market leadership.

Diagnostic Centres and Clinics

Diagnostic centres and specialty clinics support the ECMO ecosystem through patient monitoring, specialized diagnostics, follow-up care, simulation-based education, and clinician training. These facilities play an important role in strengthening workforce competency while collaborating with hospitals for advanced ECMO procedures and critical care management.

Diagnostic centres and clinics contribute nearly 8% of ECMO-related applications. Increasing demand for specialized monitoring services, clinical education programs, and advanced diagnostic technologies continues to create growth opportunities within this segment.

Ambulatory Surgical Centres

Ambulatory surgical centres represent a developing application segment as portable and compact ECMO technologies improve the feasibility of extracorporeal support during selected high-risk surgical procedures. These facilities are increasingly focusing on emergency preparedness and advanced perioperative care for complex cardiovascular and thoracic interventions.

Ambulatory surgical centres account for approximately 4% of ECMO device applications. The growing adoption of minimally invasive surgical procedures, combined with advancements in mobile ECMO platforms and compact life-support systems, is gradually expanding the role of ECMO in outpatient surgical settings.

Which segment is growing faster?

The VV ECMO segment is growing faster due to its extensive use in treating severe respiratory failure and acute respiratory distress syndrome (ARDS). Its widespread adoption across intensive care units, coupled with increasing respiratory disease prevalence and the expansion of specialized ECMO centers, has strengthened demand for VV ECMO systems. Continuous innovation in oxygenators, cannulas, and portable ECMO technologies, along with recurring demand for disposable consumables, further supports the rapid growth of this segment.

ECMO Devices Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Regional ECMO Devices Market performance concentrates in high-income regions: North America and Europe collectively account for roughly 50–70% of registry-reported runs and program capacity, while Asia-Pacific shows rapid program growth and now contributes 20–30% of runs in many datasets.

NORTH AMERICA

North America remains the leading regional market for ECMO devices, supported by highly developed healthcare infrastructure, widespread availability of specialized intensive care units, and a strong network of tertiary and quaternary hospitals. The region has established ECMO programs with multidisciplinary clinical teams capable of managing complex respiratory and cardiac conditions, resulting in consistently high utilization of ECMO systems. Continuous investments in portable ECMO platforms, transport-capable consoles, advanced oxygenators, and digital patient monitoring technologies are further strengthening market demand. In addition, favorable reimbursement systems, ongoing clinical research, and increasing adoption of extracorporeal life support in emergency medicine continue to accelerate market expansion.

North America accounts for approximately 35% of the global ECMO devices market. The growing number of ECMO retrieval programs, increasing procurement of disposable oxygenators and circuit kits, and continued expansion of critical care services are reinforcing the region's leadership. Strong manufacturer presence, rapid adoption of technological innovations, and increasing emphasis on improving patient outcomes are expected to sustain long-term market growth.

EUROPE

Europe represents a mature and well-established ECMO devices market, characterized by an extensive network of specialized hospitals, centralized referral systems, and standardized critical care protocols. Healthcare providers across the region continue to integrate ECMO therapy into the management of severe respiratory failure, cardiogenic shock, and post-cardiac surgery complications. Ongoing investments in intensive care modernization, advanced perfusion technologies, and clinician training programs are enhancing procedural efficiency and supporting wider clinical adoption. Collaborative research initiatives and cross-border healthcare partnerships also contribute to technological advancement and improved patient management.

Europe contributes approximately 25% of the global ECMO devices market. Increasing demand for high-performance oxygenators, portable ECMO systems, and long-term service agreements continues to support procurement across healthcare facilities. Rising awareness of advanced life-support therapies, continuous improvements in hospital infrastructure, and expanding ECMO treatment capabilities are expected to drive sustained market development throughout the region.

ASIA-PACIFIC

Asia-Pacific is the fastest-growing regional market for ECMO devices, driven by rapid healthcare infrastructure development, expanding intensive care capacity, and increasing investment in advanced medical technologies. The growing prevalence of respiratory diseases, cardiovascular disorders, and critical illnesses has encouraged hospitals to establish dedicated ECMO programs equipped with modern consoles, oxygenators, and monitoring systems. Healthcare providers are also investing in clinician training, simulation programs, and transport-capable ECMO technologies to improve treatment accessibility and emergency response capabilities. Increasing government support for healthcare modernization further contributes to regional market expansion.

Asia-Pacific accounts for approximately 25% of the global ECMO devices market. Rising demand for advanced critical care services, growing adoption of portable ECMO systems, and increasing procurement of disposable consumables are creating substantial opportunities for manufacturers. Expanding healthcare expenditure, improving access to specialized treatment, and continuous technological innovation are expected to strengthen the region's position in the global ECMO devices market.

MIDDLE EAST & AFRICA

The Middle East & Africa represents an emerging market for ECMO devices, supported by ongoing investments in tertiary hospitals, specialized cardiac centers, and advanced intensive care facilities. Several countries are strengthening critical care capabilities to address the increasing burden of severe respiratory and cardiovascular diseases while improving access to extracorporeal life-support technologies. Hospitals are expanding ECMO programs through collaborations with international manufacturers, investments in clinician training, and procurement of modern oxygenators, pumps, and portable ECMO systems. Growing awareness of advanced critical care therapies is also encouraging gradual adoption across both public and private healthcare institutions.

The Middle East & Africa accounts for approximately 8% of the global ECMO devices market. Increasing healthcare expenditure, expansion of specialized intensive care services, and rising government initiatives to modernize hospital infrastructure continue to support regional growth. In addition, improving supply chain networks, stronger distributor partnerships, and increasing availability of ECMO consumables are helping healthcare providers enhance treatment continuity and improve patient outcomes across the region.

Which region dominates the ECMO Devices Industry?

North America dominates the ECMO Devices Industry owing to its advanced healthcare infrastructure, extensive network of specialized ECMO centers, and strong adoption of critical care technologies. The region benefits from well-established hospital-based ECMO programs, dedicated transport services, favorable reimbursement policies, and ongoing investments in advanced life-support systems. High utilization of ECMO devices, continuous technological innovation, and increasing demand for portable ECMO platforms and consumables continue to reinforce North America's leadership in the global market.

List of Top ECMO Devices Companies

• Microport Scientific
• Maquet Holding
• Medtronic
• Terumo Cardiovascular
• Medos
• Nipro Medical
• Sorin

Top Two Companies with Highest Market Share:

• Getinge / MAQUET (Maquet Holding): Multiple industry analyses report Getinge/MAQUET with approximately 20% market share in ECMO systems and disposables in recent competitive mappings, supported by a wide product portfolio covering consoles, oxygenators and circuit kits and distribution across >50 countries.
• Medtronic: Medtronic appears among the top suppliers in 10–18% of procurement and market analyses, with its ECMO-relevant offerings (pumps, oxygenators, accessories) used in numerous tertiary centers and forming a key competitor in consumable and console segments.

Investment Analysis and Opportunities

Investment in the ECMO Devices Market is increasingly focused on expanding critical care capacity through the procurement of advanced ECMO consoles, transport-capable systems, and recurring consumables. Healthcare providers are prioritizing investments in portable ECMO platforms, digital monitoring technologies, and integrated service contracts to improve operational efficiency and patient outcomes. At the same time, manufacturers are strengthening long-term partnerships with hospitals by offering comprehensive maintenance services, technical support, and clinician education programs alongside equipment sales.

Approximately 30% of new ECMO equipment investments are directed toward portable and transport-enabled systems, reflecting the growing importance of interhospital patient transfer capabilities. Recurring demand for oxygenators, circuit kits, and other disposable components further creates stable revenue opportunities, while integrated training and service offerings continue to enhance customer retention and support the expansion of ECMO programs.

New Product Development

New product development in the ECMO Devices Market is centered on creating compact, lightweight, and technologically advanced systems that improve portability, ease of use, and clinical performance. Manufacturers are introducing next-generation ECMO consoles with integrated monitoring systems, intelligent user interfaces, and enhanced connectivity to support rapid deployment in both hospital and transport environments. Innovation is also focused on improving oxygenator efficiency, hemocompatible materials, and disposable circuit designs to enhance patient safety and reduce treatment-related complications.

Modern ECMO systems deliver flow measurement accuracy of approximately 95%, enabling clinicians to achieve precise circulatory support and improve treatment consistency. Continuous advancements in sensor integration, biocompatible coatings, compact pump technologies, and single-use consumables are further enhancing device reliability, simplifying clinical workflows, and supporting broader adoption of ECMO across advanced critical care settings.

Five Recent Developments

• ELSO registry reporting showed 12,963 adult ECMO runs in 2022, confirming adult dominance in annual volumes.
• Median adult ECMO runs per center rose from 4 (2009) to 15 (recent), demonstrating higher per-center utilization.
• Portable/transport-capable ECMO consoles now figure in 20–35% of new procurements in large system tenders.
• Leading supplier competitive mappings report Getinge/MAQUET with about 20% market share and Medtronic in the 10–18% band among major ECMO suppliers.
• High-volume acquisition patterns show hospitals ordering 1–6 consoles per program and maintaining consumable stocks covering 2–8 weeks of projected runs.

Report Coverage of ECMO Devices Market

This ECMO Devices Market Research Report covers device segmentation (VV ECMO 55–65%, VA ECMO 30–40%, AV ECMO <10%), end-user segmentation (hospitals 60–80%, clinics/diagnostic centers <10%, ambulatory/surgical centers <5%) and regional distribution (North America 30–40%, Europe 20–30%, Asia-Pacific 20–30%, MEA <10%). It quantifies utilization with ELSO-reported runs (adult 12,963, pediatric 2,457, neonatal 1,383 in 2022), program volumes (median adult runs per center moved from 4 to 15 since 2009), and operational metrics (typical cannulation targets 30–90 minutes and median VV run durations of 5–14 days). The scope includes capital vs. consumable purchasing splits—consoles and capital equipment versus recurring oxygenator and circuit-kit demand where 1 kit is consumed per run—and service models (training commitments averaging 16–40 hours per clinician annually and program support bundles covering 12–36 month service contracts). Coverage also maps supplier presence and competitive concentration, where leading suppliers hold single-digit to low-twenties percent shares, helping procurement teams evaluate console, consumable and training offers for ECMO Devices Market Forecasting and ECMO Devices Market Opportunities.

ECMO Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 296.38 Million in 2026
Market Size Value By	USD 445.06 Million by 2035
Growth Rate	CAGR of 4.62% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : VV ECMO VA ECMO AV ECMO By Application : Hospitals Diagnostic Centre Clinics Ambulatory Surgical Centre
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample